Veterinary Medicine Commons^™

In Vitro Analysis Of Equine Platelet Rich Plasma And In Vivo Effect Of Cytokines After Repeated Intra-Articular Injections In Osteoarthritic Joints, Carlos Aguilar Miranda

LSU Master's Theses

INTRODUCTION- The use of biologic therapies like platelet rich plasma (PRP) has a potential benefit for the treatment of osteoarthritis in horses. However, key parts of it are still unknown. The objective is to evaluate the degree of platelet activation achieved when in contact with exogenous activators. As well as the long-term effect in the anabolism and catabolism of cytokines involved in equine osteoarthritis.

MATERIAL AND METHODS-In one in vitro study PRP was collected from 6-horses using a commercially available kit. Platelets were exposed to PBS as negative control or to varying concentrations of CaCl2. Activation was determined via cell …

Chikungunya Virus Infection-Associated Bone And Joint Disease, Brad A. Goupil

LSU Doctoral Dissertations

Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that circulates predominantly in tropical and subtropical regions. Infection results in severe debilitating polyarthralgia during the acute phase of disease, and reports suggest that chronic arthralgia lasting months to years after the initial infection can occur. More severe and prolonged disease has been associated with pre-existing joint disease, though this has not been experimentally examined. In the research presented herein, two established mouse models (adult IRF 3/7 -/- -/- and wild-type C57BL/6J mice) were utilized to characterize CHIKV-associated bone and joint disease and evaluate its impact on the progression of pre-existing osteoarthritis (OA) …

Matrix Metalloproteinase 3, Matrix Metalloproteinase 13, And Tissue Inhibitor Of Metalloproteinase 1 Concentrations In Normal And Naturally-Occurring Osteoarthritic Canine Stifles, Blaine Allen Burkert

LSU Master's Theses

Osteoarthritis is arguably the most common ailment in both dogs and people in the developed World. Treatment for osteoarthritis is currently symptomatic. Development of therapies designed at stopping the progression of osteoarthritis, require a method of evaluating efficacy. Objective analysis by measuring joint metabolism via clinical trials of the cross-over design is currently not possible with the methods utilized. Extracellular matrix degradation is a hallmark of osteoarthritis. The matrix metalloproteinases are major degradative enzymes. There are currently no commercially available assays to measure canine matrix metalloproteinases. Human and canine matrix metalloproteinases are highly homologous. The use of antibodies and assays …